
Sign up to save your podcasts
Or


This week, the Derms on Drugs are back with another literature speed-run—think 3D chess meets derm nerd nirvana. We’re answering questions you didn’t even know you had (and a few you wish you didn’t).
Here’s what we’re tackling:
Do herbal supplements turn up dermatomyositis?
Can biologics cut down on blood clots in HS?
Wait… does Claritin supercharge isotretinoin?
Is Sotyktu stirring up rosacea?
How good is the new oral IL-23 inhibitor icotrokinra for psoriasis?
Any fresh weapons against demodex?
Anything new for those stubborn pemphigus oral lesions?
What to do when your patient is resistant to multiple botulinum toxins?
And—holy grail alert—can we actually prevent chemo-induced alopecia in breast cancer?
By Scholars in Medicine4.7
3030 ratings
This week, the Derms on Drugs are back with another literature speed-run—think 3D chess meets derm nerd nirvana. We’re answering questions you didn’t even know you had (and a few you wish you didn’t).
Here’s what we’re tackling:
Do herbal supplements turn up dermatomyositis?
Can biologics cut down on blood clots in HS?
Wait… does Claritin supercharge isotretinoin?
Is Sotyktu stirring up rosacea?
How good is the new oral IL-23 inhibitor icotrokinra for psoriasis?
Any fresh weapons against demodex?
Anything new for those stubborn pemphigus oral lesions?
What to do when your patient is resistant to multiple botulinum toxins?
And—holy grail alert—can we actually prevent chemo-induced alopecia in breast cancer?

5,160 Listeners

1,150 Listeners

4,926 Listeners

9,265 Listeners

634 Listeners

146 Listeners

1,901 Listeners

227 Listeners

51 Listeners

1,622 Listeners

3,460 Listeners

8,600 Listeners

421 Listeners

6 Listeners

6 Listeners